Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > IMPL Impel NeuroPharma > Detailed Quotes

IMPL Impel NeuroPharma

4.870
-0.070-1.42%
Close 09/30 16:00 ET
4.8700.0000.00%
Post Mkt Price 09/30 16:31 ET
High
5.390
Open
4.910
Turnover
169.11K
Low
4.800
Pre Close
4.940
Volume
33.72K
Market Cap
115.61M
P/E(TTM)
Loss
52wk High
12.560
Shares
23.74M
P/E(Static)
Loss
52wk Low
4.800
Float Cap
51.01M
Bid/Ask %
90.48%
Historical High
34.750
Shs Float
10.47M
Volume Ratio
0.66
Historical Low
4.800
Dividend TTM
--
Div Yield TTM
--
P/B
29.52
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.32%
Amplitude
11.94%
Avg Price
5.015
Lot Size
1
Float Cap
51.01M
Bid/Ask %
90.48%
Historical High
34.750
Shs Float
10.47M
Volume Ratio
0.66
Historical Low
4.800
Dividend TTM
--
P/B
29.52
Dividend LFY
--
Turnover Ratio
0.32%
Amplitude
11.94%
Avg Price
5.015
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Impel Pharmaceuticals, Inc. operates as clinical stage biotechnology firm that develops medical devices. It offers intranasal drug treatments for central nervous system (CNS) disorders. The firm product candidates includes TRUDHESA, INP105, and INP107. The company was founded by Rodney J. Y. Ho, John D. Hoekman, and Michael P. Hite in 2008 and is headquartered in Seattle, WA.
CEO: Mr. Adrian Adams
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...